research

Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript

Seeking Alpha

2 min read

0 likes

⚡ Quantum Brief

Globus Medical reported Q4 2025 earnings on February 24, 2026, with CEO Keith Pfeil and CFO Kyle Kline leading the call, highlighting financial performance and strategic updates. The company emphasized forward-looking statements, cautioning investors about potential risks outlined in its 2025 Form 10-K and subsequent SEC filings, available on its corporate website. Analysts from major firms, including RBC Capital, Truist Securities, and BofA, participated, signaling strong institutional interest in Globus Medical’s growth trajectory and market position. Key discussion points included operational milestones, revenue trends, and R&D investments, though specific financial figures were not detailed in the transcript excerpt provided. The earnings call was accessible via webcast, reinforcing transparency and shareholder engagement as priorities for the medical device manufacturer.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

SA Transcripts158.6K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Globus Medical, Inc. (GMED) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Company Participants Brian Kearns - Senior Vice President of Business Development & Investor RelationsKeith Pfeil - CEO, President & DirectorKyle Kline - Senior VP & CFO Conference Call Participants Shagun Singh Chadha - RBC Capital Markets, Research DivisionRichard Newitter - Truist Securities, Inc., Research DivisionTravis Steed - BofA Securities, Research DivisionMathew Blackman - TD Cowen, Research DivisionMatthew Miksic - Barclays Bank PLC, Research DivisionAnna Runci - Piper Sandler & Co., Research DivisionCaitlin Cronin - Canaccord Genuity Corp., Research DivisionDavid Saxon - Needham & Company, LLC, Research DivisionRyan Zimmerman - BTIG, LLC, Research DivisionKeith Hinton - Prime Executions, Inc., Research DivisionThomas Stephan - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Welcome to Globus Medical's Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead. Brian KearnsSenior Vice President of Business Development & Investor Relations Thank you, Dana, and thank you, everyone, for being with us today. Joining today's call from Globus Medical will be Keith Pfeil, President and CEO; and Kyle Kline, Chief Financial Officer. This review is being made available via webcast accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com. Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2025 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K, are available on our website.

Read Original

Source Information

Source: Seeking Alpha

Website: https://seekingalpha.com/feed.xml

Discussion

0 professional contributions

Be the first to add a constructive contribution.